ZBIO · Zenas BioPharma, Inc.
Market Cap
$2.06B
Shares
65.18M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-13 | 2026-06-30 | |
| 8-K | 2026-08-13 | 2026-08-12 | |
| 8-K | 2026-05-13 | 2026-05-11 | |
| 10-Q | 2026-05-13 | 2026-03-31 | |
| 8-K | 2026-03-31 | 2026-03-26 | |
| DEF 14A | 2026-03-16 | 2026-05-11 | |
| 8-K | 2026-03-16 | — | |
| 10-K | 2026-03-16 | 2025-12-31 | |
| 8-K | 2026-02-13 | 2026-02-10 | |
| 8-K | 2026-01-05 | — | |
| 8-K | 2025-12-15 | 2025-12-10 | |
| 8-K | 2025-11-12 | — | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K | 2025-10-27 | — | |
| 8-K | 2025-10-08 | 2025-10-07 | |
| 8-K | 2025-09-02 | — | |
| 8-K | 2025-08-12 | — | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-06-12 | 2025-06-10 | |
| 8-K | 2025-06-04 | — | |
| 10-Q | 2025-05-15 | 2025-03-31 | |
| 8-K | 2025-05-15 | — | |
| DEF 14A | 2025-04-28 | 2025-06-10 | |
| 10-K | 2025-03-11 | 2024-12-31 | |
| 8-K | 2025-02-05 | — | |
| 8-K | 2024-12-02 | — | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-11-12 | — | |
| 8-K | 2024-09-16 | — |
Showing 1–29 of 29 filings
Key facts
CIK
1953926
CUSIP
98937L105
13F (30d)
136 filings
131 filers
Visit website
Investor relations